Author

M. L. Wei

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

A. H. Shain· 2 shared R. L. Judson-Torres· 2 shared R. Torres· 2 shared U. E. Lang· 2 shared A. S. McNeal· 1 shared B. C. Bastian· 1 shared D. Grossman· 1 shared D. H. Lum· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. H. Shain

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BRAFV600E induces reversible mitotic arrest in human melanocytes via microRNA-mediated suppression of AURKB.

A. S. McNeal, R. L. Belote, H. Zeng, M. Urquijo, K. Barker, R. Torres, M. Curtin, A. H. Shain, R. H. Andtbacka, S. L. Holmen, D. H. Lum, T. McCalmont, M. W. VanBrocklin, D. Grossman, M. L. Wei, , R. L. Judson-Torres

This study identifies microRNA-mediated suppression of AURKB as a mechanism by which BRAFV600E induces reversible mitotic arrest in human melanocytes, contributing to nevus formation.

bioRxiv · May 21, 2020Cancer Biology

A machine-learning classifier trained with microRNA ratios to distinguish melanomas from nevi

R. Torres, U. E. Lang, M. Hejna, S. J. Shelton, N. M. Joseph, A. H. Shain, I. Yeh, M. L. Wei, M. C. Oldham, B. C. Bastian, R. L. Judson-Torres

This study develops a machine learning classifier using microRNA ratios to distinguish melanomas from nevi, achieving 83% sensitivity and 71-83% specificity across multiple datasets.

bioRxiv · Dec 27, 2018 · PreprintCancer Biology